Suppr超能文献

一种反映突变型HRAS驱动的鳞状细胞癌表型异质性的细胞模型。

A cellular model reflecting the phenotypic heterogeneity of mutant HRAS driven squamous cell carcinoma.

作者信息

Cantariño Neus, Fernández-Figueras M Teresa, Valero Vanesa, Musulén Eva, Malinverni Roberto, Granada Isabel, Goldie Stephen J, Martín-Caballero Juan, Douet Julien, Forcales Sonia-Vanina, Buschbeck Marcus

机构信息

Institute of Predictive and Personalized Medicine of Cancer, Campus Can Ruti, Badalona, Spain.

Department Of Pathology, Hospital Universitari Germans Trias I Pujol, Campus Can Ruti, Badalona, Spain.

出版信息

Int J Cancer. 2016 Sep 1;139(5):1106-16. doi: 10.1002/ijc.30139. Epub 2016 May 5.

Abstract

Squamous cell carcinomas have a range of histopathological manifestations. The parameters that determine this clinically observed heterogeneity are not fully understood. Here, we report the generation of a cell culture model that reflects part of this heterogeneity. We have used the catalytic subunit of human telomerase hTERT and large T to immortalize primary UV-unexposed keratinocytes. Then, mutant HRAS G12V has been introduced to transform these immortal keratinocytes. When injected into immunosuppressed mice, transformed cells grew as xenografts with distinct histopathological characteristics. We observed three major tissue architectures: solid, sarcomatoid and cystic growth types, which were primarily composed of pleomorphic and basaloid cells but in some cases displayed focal apocrine differentiation. We demonstrate that the cells generated represent different stages of skin cancerogenesis and as such can be used to identify novel tumor-promoting alterations such as the overexpression of the PADI2 oncogene in solid-type SCC. Importantly, the cultured cells maintain the characteristics from the xenograft they were derived from while being amenable to manipulation and analysis. The availability of cell lines representing different clinical manifestations opens a new tool to study the stochastic and deterministic factors that cause case-to-case heterogeneity despite departing from the same set of oncogenes and the same genetic background.

摘要

鳞状细胞癌具有一系列组织病理学表现。决定这种临床观察到的异质性的参数尚未完全了解。在此,我们报告了一种反映这种异质性部分特征的细胞培养模型的构建。我们利用人端粒酶催化亚基hTERT和大T抗原使未暴露于紫外线的原代角质形成细胞永生化。然后,引入突变型HRAS G12V来转化这些永生化的角质形成细胞。当将转化细胞注射到免疫抑制小鼠体内时,它们会以具有不同组织病理学特征的异种移植物形式生长。我们观察到三种主要的组织结构:实体型、肉瘤样型和囊性生长型,这些主要由多形性和基底样细胞组成,但在某些情况下表现出局灶性顶泌汗腺分化。我们证明所产生的细胞代表皮肤癌发生的不同阶段,因此可用于鉴定新的促肿瘤改变,例如实体型鳞状细胞癌中PADI2癌基因的过表达。重要的是,培养的细胞保留了其来源的异种移植物的特征,同时易于进行操作和分析。代表不同临床表现的细胞系的可用性为研究导致病例间异质性的随机和确定性因素提供了一种新工具,尽管这些因素源于同一组癌基因和相同的遗传背景。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验